rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Orthofix Medical Inc.

OFIX · Nasdaq

Health CareMedical DevicesNot moving yet

OFIX stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 39 weeks. It is 11.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 39
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$13.6M
Insider sales, 12 months
$13.2M
Officials’ trades on record
0
Institutions holding
135 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$5.1M$0$5.1MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months17
Sale orders, 12 months30
Buyers · sellers7 · 9
WhoDidSharesTraded
Patrick FisherPresident, Global Limb Reconsold150at $9.441 Oct 2026filed 5 Oct 2026
Juniper Investment Company, Llc10% ownersold190,000at $8.8621 Sep 2026filed 22 Sep 2026
Juniper Investment Company, Llc10% ownerbought190,000at $8.8621 Sep 2026filed 23 Sep 2026
Juniper Investment Company, Llc10% ownersold120,000at $8.7418 Sep 2026filed 22 Sep 2026
Juniper Investment Company, Llc10% ownerbought120,000at $8.7418 Sep 2026filed 23 Sep 2026
Patrick FisherPresident, Global Limb Reconsold150at $9.391 Sep 2026filed 3 Sep 2026
Patrick FisherPresident, Global Limb Reconsold1,295at $10.0918 Aug 2026filed 20 Aug 2026
Juniper Investment Company, Llc10% ownersold20,000at $10.0117 Aug 2026filed 18 Aug 2026
Juniper Investment Company, Llc10% ownersold19,500at $10.3814 Aug 2026filed 18 Aug 2026
Aviva McPherronPres, Global Ops & Qualsold3,670at $9.3818 Jun 2026filed 22 Jun 2026
Juniper Investment Company, Llc10% ownersold242,000at $10.7022 May 2026filed 29 May 2026
Engine Capital Management, Lp10% ownerbought18,192at $12.207 May 2026filed 7 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders135-3 on the quarter
New · exited25 · 28
Reported value$343.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Engine Capital Management, LPadded · filed 14 Aug 20264,575,675$41.8M+184,896+4.2%
Juniper Investment Company, LLCadded · filed 14 Aug 20264,442,543$40.6M+465,584+11.7%
Rubric Capital Management LPunchanged · filed 14 Aug 20263,721,715$34.0M00.0%
BlackRock, Inc.added · filed 7 Aug 20263,326,560$30.4M+118,771+3.7%
PARADIGM CAPITAL MANAGEMENT INCreduced · filed 13 Aug 20263,300,499$30.2M-4,400−0.1%
ARMISTICE CAPITAL, LLCadded · filed 14 Aug 20263,264,000$29.8M+564,000+20.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,731,108$15.8M+75,659+4.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,048,081$9.6M+109,196+11.6%
STATE STREET CORPadded · filed 7 Aug 2026953,148$8.7M+45,716+5.0%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026887,282$8.1M+698,158+369.2%
31 Mar 2023 – 30 Jun 2026
120132144Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Patrick Fisher Company insiderPresident, Global Limb Recon · last 1 Oct 20260 · 6
John A. Bartholdson Company insider10% owner · last 21 Sep 20262 · 0
Juniper Investment Company, LLC Company insider10% owner · last 21 Sep 20262 · 5
Alexis P. Michas Company insider10% owner · last 17 Aug 20260 · 2
Aviva McPherron Company insiderPres, Global Ops & Qual · last 18 Jun 20260 · 4
Alan Lee Bazaar Company insiderDirector · last 10 Jun 20263 · 0
Charles R. Kummeth Company insiderDirector · last 10 Jun 20260 · 0
Jason Hannon Company insiderDirector · last 10 Jun 20260 · 0
John B. Henneman III Company insiderDirector · last 10 Jun 20261 · 0
Michael E. Paolucci Company insiderDirector · last 10 Jun 20261 · 0
Michael Finegan Company insiderDirector · last 10 Jun 20260 · 11
Shweta Maniar Company insiderDirector · last 10 Jun 20260 · 1

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202568.8%
Operating profit marginFY 2025 · to 31 Dec 2025-9.9%
Free cash flow marginFY 2025 · to 31 Dec 2025-0.2%
Return on capital employedFY 2025 · to 31 Dec 2025-12.0%
Debt to equityFY 2025 · to 31 Dec 20250.35×
Interest coverFY 2025 · to 31 Dec 20254.66×
Research spendFY 2025 · to 31 Dec 20258.0%
Share count trendFY 2025 · to 20 Feb 20260.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$82.0M
Free cash flowFY 2025 · to 31 Dec 2025−$1.3M

Analyst forecasts

No analyst forecasts yet.